Highview Capital Management’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.58M Sell
13,207
-61
-0.5% -$8K 0.57% 50
2025
Q4
$1.81M Buy
13,268
+54
+0.4% +$7.77K 0.64% 45
2025
Q3
$1.95M Sell
13,214
-130
-1% -$18K 0.72% 44
2025
Q2
$1.73M Buy
+13,344
New +$1.62M 0.67% 43
2024
Q4
Sell
-14,879
Closed -$2.01M 130
2024
Q3
$2.01M Buy
14,879
+438
+3% +$58.6K 0.82% 32
2024
Q2
$1.96M Buy
14,441
+3,392
+31% +$461K 0.81% 33
2024
Q1
$1.43M Buy
+11,049
New +$1.34M 0.64% 46

Other funds holding XYL

Highview Capital Management's XYL Position: Q1 2026 in Review

Highview Capital Management reduced its Xylem (XYL) stake by 0.46% in Q1 2026, selling an estimated $8K and leaving 13,207 shares worth $1.58M. The position accounts for 0.57% of the portfolio, ranked #50.

Highview Capital Management first reported a position in XYL in Q1 2024 and has held it in 7 quarters since. The position peaked at $2.01M in Q3 2024. 1,107 funds tracked by Wall St. Rank hold XYL as of Q1 2026.

  • Highview Capital Management held 13,207 shares of Xylem worth $1.58M as of Q1 2026.
  • Highview Capital Management sold 61 Xylem shares in Q1 2026, an estimated $8K.
  • Xylem made up 0.57% of Highview Capital Management's portfolio in Q1 2026, its #50 holding.
  • Highview Capital Management first reported a position in Xylem in Q1 2024 and has held it in 7 quarters since.
  • Highview Capital Management's Xylem position peaked at $2.01M in Q3 2024.
  • 1,107 funds tracked by Wall St. Rank held Xylem as of Q1 2026.

Based on Highview Capital Management's 13F filing for Q1 2026, filed 8 May 2026.